//
home

Latest Post

The 2017 Hepatitis C Treatment Landscape

Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, particularly when it comes to direct-acting antiviral medications. This included various drug approvals and access improvements for hepatitis C medications, including Daklinza, Epclusa, Sovaldi/velpatasvir, Viekira, and Zepatier. As we make our way deeper into 2017, this breakneck speed of new … Continue reading

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 170 other followers

Twitter Updates

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 170 other followers

Like Us On Facebook!

February 2017
M T W T F S S
« Jan    
 12345
6789101112
13141516171819
20212223242526
2728  

Archives